Tourmaline Bio (TRML) Institutional Ownership → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free TRML Stock Alerts $15.25 +0.83 (+5.76%) (As of 05/15/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Tourmaline Bio (NASDAQ:TRML)CurrentInstitutional OwnershipPercentage91.89%Number ofInstitutional Buyers(last 12 months)19TotalInstitutional Inflows(last 12 months)$180.35MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$414.05K Get TRML Insider Trade Alerts Want to know when executives and insiders are buying or selling Tourmaline Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TRML Institutional Buying and Selling by Quarter Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WayNanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront!See how with its ongoing expansion and development Tourmaline Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2024Darwin Global Management Ltd.465,000$10.65M1.4%N/A1.813% 5/15/2024Avoro Capital Advisors LLC2,222,222$50.89M0.6%+155.9%8.664% 5/15/2024 Altitude Crest Partners Inc.47,400$1.09M0.5%N/A0.185% 5/15/2024 Affinity Asset Advisors LLC50,000$1.15M0.1%-26.6%0.195% 5/14/2024 Qiming U.S. Ventures Management LLC741,691$16.99M18.9%+15.6%2.892% 5/14/2024 Nan Fung Group Holdings Ltd20,987$481K0.4%N/A0.082% 5/14/2024 StemPoint Capital LP274,219$6.28M1.7%N/A1.069% 5/10/2024 Vanguard Group Inc.914,519$20.94M0.0%+19.7%3.566% 5/7/2024 Swiss National Bank32,000$733K0.0%N/A0.125% 5/2/2024 Jennison Associates LLC1,115,251$25.54M0.0%N/A4.348% 5/1/2024 BNP Paribas Financial Markets1,346$31K0.0%N/A0.005% 4/29/2024 China Universal Asset Management Co. Ltd.4,939$113K0.0%+109.5%0.019% 4/19/2024 Denali Advisors LLC5,600$128K0.0%N/A0.022% 2/15/2024Great Point Partners LLC672,885$17.62M3.0%N/A3.308% 2/14/2024Braidwell LP906,820$23.74M0.9%N/A4.458% 2/14/2024Avoro Capital Advisors LLC868,407$22.74M0.3%N/A4.269% 2/14/2024RTW Investments LP398,850$10.44M0.2%N/A1.961% 2/13/2024 Affinity Asset Advisors LLC68,081$1.78M0.3%N/A0.335% 2/7/2024 Jump Financial LLC14,500$380K0.0%N/A0.071% 2/7/2024 Vivo Capital LLC591,882$15.50M1.3%N/A2.910% 1/30/2024 BML Capital Management LLC245,500$6.43M4.9%N/A1.207% (Data available from 1/1/2016 forward) TRML Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TRML shares? During the previous two years, 19 institutional investors and hedge funds held shares of Tourmaline Bio. The most heavily invested institutionals were Avoro Capital Advisors LLC ($50.89M), Jennison Associates LLC ($25.54M), Braidwell LP ($23.74M), Vanguard Group Inc. ($20.94M), Great Point Partners LLC ($17.62M), Qiming U.S. Ventures Management LLC ($16.99M), and Vivo Capital LLC ($15.50M).Learn more on TRML's institutional investors. What percentage of Tourmaline Bio stock is owned by institutional investors? 91.89% of Tourmaline Bio stock is owned by institutional investors. Learn more on TRML's institutional investor holdings. Which institutional investors have been buying Tourmaline Bio stock? Of the 19 institutional investors that purchased Tourmaline Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Avoro Capital Advisors LLC ($2.22M), Jennison Associates LLC ($1.12M), Braidwell LP ($906.82K), Great Point Partners LLC ($672.89K), Vivo Capital LLC ($591.88K), Darwin Global Management Ltd. ($465K), and RTW Investments LP ($398.85K). How much institutional buying is happening at Tourmaline Bio? Institutional investors have bought a total of 7,335,892 shares in the last 24 months. This purchase volume represents approximately $180.35M in transactions. Which Tourmaline Bio major shareholders have been selling company stock? The following institutional investors have sold Tourmaline Bio stock in the last 24 months: Affinity Asset Advisors LLC ($18.08K). How much institutional selling is happening at Tourmaline Bio? Institutional investors have sold a total of 18,081 shares in the last 24 months. This volume of shares sold represents approximately $414.05K in transactions. Related Companies: TScan Therapeutics Major Shareholders Aura Biosciences Major Shareholders Solid Biosciences Major Shareholders Replimune Group Major Shareholders Ocugen Major Shareholders Tenaya Therapeutics Major Shareholders MeiraGTx Major Shareholders Jasper Therapeutics Major Shareholders Black Diamond Therapeutics Major Shareholders C4 Therapeutics Major Shareholders This page (NASDAQ:TRML) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 Tech Stocks to Buy for 2024Daily Market AlertsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tourmaline Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
